[
  {
    "住院流水号": "19121300000258",
    "临床诊断": "肺部阴影",
    "病理类型": "常规",
    "病理诊断结果": "“右上叶后段活检组织”:送检组织主要为血管及纤维素样渗出物，散在淋巴细胞，未见肯定恶性依据。",
    "镜下所见": " ",
    "肉眼所见": "灰褐组织一块，直径0.05cm，试做。",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "2018-06-25 00:00:00",
    "报告时间": "2018-06-27 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "肺部阴影",
    "病理类型": "常规",
    "病理诊断结果": "“右上叶后段活检组织”:送检组织为血管、纤维组织及纤维素样渗出物，散在淋巴细胞浸润，未见肯定恶性依据。",
    "镜下所见": " ",
    "肉眼所见": "灰白组织一块，直径0.1cm，试做。",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "2018-06-25 00:00:00",
    "报告时间": "2018-06-27 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "肺部阴影",
    "病理类型": "常规",
    "病理诊断结果": "“右上叶后段活检组织”:送检组织为纤维组织及少量软骨组织，极少量纤维素样渗出物，未见肯定恶性依据。",
    "镜下所见": " ",
    "肉眼所见": "灰白组织一块，直径0.1cm。",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "2018-06-25 00:00:00",
    "报告时间": "2018-06-27 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "乳房肿块",
    "病理类型": "常规",
    "病理诊断结果": "“左乳2点肿物穿刺标本”乳腺组织内散在少量异型细胞浸润，考虑恶性肿瘤，淋巴瘤不能除外，待免疫组化检查进一步辅助诊断。\n“左乳5点肿物穿刺标本”乳腺组织内大量异型细胞浸润，考虑恶性肿瘤，淋巴瘤不能除外，待免疫组化检查进一步辅助诊断。",
    "镜下所见": " ",
    "肉眼所见": "“左乳2点肿物CNB标本”：灰白穿刺组织4条，长1.0-1.5cm，直径0.1cm。\r\n“左乳5点肿物CNB标本”：灰白穿刺组织3条，长0.5-1.4cm，直径0.1cm。\r\n",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "2018-07-24 00:00:00",
    "报告时间": "2018-07-24 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "乳房肿块",
    "病理类型": "FISH",
    "病理诊断结果": "标本类型:蜡块\nFISH检测结果：\nt(14;18)(q32;q21) IGH/BCL 2 融合探针检测:阴性\n3q27 BCL 6 分离探针检测:阳性\n8q24 C-MYC 分离探针检测:阴性\n注： 3 % 的肿瘤细胞可见 BCL 2 红绿信号融合\n 14.02 % 的肿瘤细胞可见 BCL 6 红绿信号分离\n 4.17 % 的肿瘤细胞可见 C-MYC 红绿信号分离",
    "镜下所见": " ",
    "肉眼所见": " ",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "",
    "报告时间": "2018-08-07 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "弥漫大B细胞淋巴瘤",
    "病理类型": "骨髓",
    "病理诊断结果": "“骨髓活检”造血细胞三系增生低下+，未见异型淋巴细胞。",
    "镜下所见": "造血与脂肪组织之比30%：70%，粒红比为1.5：1,粒系↓+，Alip-，小细胞-，低分叶核-，不规则多分叶-，红系↓+,热点-，核出芽-、核间桥-、核碎裂-、多核-，胞质空泡-，巨幼变-，巨核↓+, 小圆巨核-，裸巨核-，多核巨核-，网状-，Masson-，淋巴细胞少数。\r\n\r\n\r\n\r\n\r\n\r\n",
    "肉眼所见": "骨样组织一条，0.8×0.2×0.2cm，灰褐色。",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "2018-08-30 00:00:00",
    "报告时间": "2018-09-07 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "弥漫大B细胞淋巴瘤",
    "病理类型": "分子病理",
    "病理诊断结果": "DNA;1、检测到与疾病相关突变：MYD88、IGLL5。\n2、未检测到与疾病预后相关突变点。\n3、检测到与治疗相关突变：MYD88。\n4、其他可能与疾病相关突变：TP53、PCLO、HIST1H1C、EZH2、PIM1、IGLL5。;",
    "镜下所见": " ",
    "肉眼所见": " ",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "",
    "报告时间": "2018-09-13 00:00:00"
  },
  {
    "住院流水号": "19121300000258",
    "临床诊断": "弥漫大B细胞淋巴瘤",
    "病理类型": "分子病理",
    "病理诊断结果": "DNA;1.检测到具有明确临床意义的基因变异： CD79A、TMSB4X、IGLL5、MYD882；\n2.检测到临床意义尚不明确的基因变异： FGFR3、KMT2D、MPEG1、IGLL5、STAT3、CIC、PIM1、PCLO。\n详见纸质版报告;;",
    "镜下所见": " ",
    "肉眼所见": " ",
    "免疫组化": " ",
    "报告内容": "",
    "检查时间": "",
    "报告时间": "2020-04-28 00:00:00"
  }
]